LoginRegister
    Novartis division resubmits USFDA application for biosimilar PegfilgrastimNovartis division resubmits USFDA application for biosimilar Pegfilgrastim
    Roche extends Spark Therapeutics offer worth 4.3 billion USDRoche extends Spark Therapeutics' offer worth 4.3 billion USD
    Family behind OxyContin calls opioid suit false, misleadingFamily behind OxyContin calls opioid suit false, misleading
    Cigna caps insulin prices at $25 for 30 daysCigna caps insulin prices at $25 for 30 days
    NPPA revises ceiling price of 847 formulations including Metformin, Atrovastatin; DetailsNPPA revises ceiling price of 847 formulations including Metformin, Atrovastatin; Details
    MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of CarcinogensMORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of Carcinogens
    CDSCO calls for crackdown on Buclizine sales; Mankind Pharma taken to court: ReportCDSCO calls for crackdown on Buclizine sales; Mankind Pharma taken to court: Report
    Dr Reddys arm sells US rights for Sernivo, Promises, Trianex to Encore DermatologyDr Reddy's arm sells US rights for Sernivo, Promises, Trianex to Encore Dermatology
    USFDA issues warning letter to Rajasthan based homeopathic firm and 3 othersUSFDA issues warning letter to Rajasthan based homeopathic firm and 3 others
    Pfizer participates in SpringWorks Therapeutics USD125 million Series B financingPfizer participates in SpringWorks Therapeutics' USD125 million Series B financing
    Novartis to face lawsuit over doctor kickbacksNovartis to face lawsuit over doctor kickbacks
    China to regulate all fentanyl drugs as controlled substanceChina to regulate all fentanyl drugs as controlled substance
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X